HUP0200311A2 - Aroil- vagy aralkanoil-piridazin-származékok alkalmazása gyógyszerkészítmények előállítására - Google Patents

Aroil- vagy aralkanoil-piridazin-származékok alkalmazása gyógyszerkészítmények előállítására

Info

Publication number
HUP0200311A2
HUP0200311A2 HU0200311A HUP0200311A HUP0200311A2 HU P0200311 A2 HUP0200311 A2 HU P0200311A2 HU 0200311 A HU0200311 A HU 0200311A HU P0200311 A HUP0200311 A HU P0200311A HU P0200311 A2 HUP0200311 A2 HU P0200311A2
Authority
HU
Hungary
Prior art keywords
group
independently
hal
atoms
substituted
Prior art date
Application number
HU0200311A
Other languages
English (en)
Inventor
Norbert Beier
Claus Fittschen
Franz-Werner Kluxen
Jonas Rochus
Michael Wolf
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0200311A2 publication Critical patent/HUP0200311A2/hu
Publication of HUP0200311A3 publication Critical patent/HUP0200311A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A találmány tárgya (I) általános képletű vegyületek - ahol B jelentéseA, OA, NH2, NHA, NAA' vagy egy aromás heterociklusos csoport, amely 1-4 N, O és/vagy S atomot tartalmaz, és amely szubsztituálatlan, vagypedig mono-, di- vagy triszubsztituált lehet Hal, A és/vagy OAáltalános képletű csoporttal; Q vagy nincs jelen, vagy pedig 1-6szénatomos alkiléncsoportot jelent; R1 és R2 jelentése egymástólfüggetlenül -OH, -OR5, -S-R5, -SO-R5, -SO2-R5, Hal, -NO2, -NH2, -NHR5vagy -NR5R6 általános képletű csoport; vagy R1 és R2 együtt -O-CH2-O-csoportot képez; R5 és R6 jelentése egymástól függetlenül A, 3-7szénatomos cikloalkilcsoport, 4-8 szénatomos metilén-cikloalkil-csoport vagy 2-8 szénatomos alkenilcsoport; A és A' jelentéseegymástól függetlenül 1-10 szénatomos alkilcsoport, amelyszubsztituálva lehet 1-5 F és/vagy C1 atommal; és Hal jelentése F, C1,Br vagy I és/vagy azok fiziológiailag elfogadható sóinak azalkalmazása oszteoporózis, tumorok, ateroszklerózis, reumatoidarthritis, szklerózis multiplex, diabetes mellitus, fekélyképződésesvastagbélgyulladás és AIDS kezelésére alkalmas gyógyászatikészítmények előállítására. Ó
HU0200311A 1999-04-06 2000-03-15 Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions HUP0200311A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19915364A DE19915364A1 (de) 1999-04-06 1999-04-06 Verwendung von Arylalkanoylpyridazinen

Publications (2)

Publication Number Publication Date
HUP0200311A2 true HUP0200311A2 (hu) 2002-11-28
HUP0200311A3 HUP0200311A3 (en) 2002-12-28

Family

ID=7903583

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200311A HUP0200311A3 (en) 1999-04-06 2000-03-15 Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions

Country Status (18)

Country Link
EP (1) EP1143944A3 (hu)
JP (1) JP2002541095A (hu)
KR (1) KR20020000550A (hu)
CN (1) CN1355702A (hu)
AR (1) AR023261A1 (hu)
AU (1) AU3811600A (hu)
BR (1) BR0009549A (hu)
CA (1) CA2367051A1 (hu)
CZ (1) CZ20013598A3 (hu)
DE (1) DE19915364A1 (hu)
HU (1) HUP0200311A3 (hu)
ID (1) ID30381A (hu)
MX (1) MXPA01010034A (hu)
NO (1) NO20014845L (hu)
PL (1) PL350963A1 (hu)
RU (1) RU2001129703A (hu)
WO (1) WO2000059484A2 (hu)
ZA (1) ZA200109120B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040087335A (ko) 2002-03-01 2004-10-13 야마노우치세이야쿠 가부시키가이샤 질소 함유 복소환 화합물
DE10224888A1 (de) * 2002-06-05 2003-12-24 Merck Patent Gmbh Pyridazinderivate
DE10225574A1 (de) * 2002-06-10 2003-12-18 Merck Patent Gmbh Aryloxime
WO2005002590A1 (ja) * 2003-07-01 2005-01-13 Astellas Pharma Inc. 骨量増加誘導剤
AR067354A1 (es) * 2007-06-29 2009-10-07 Sunesis Pharmaceuticals Inc Compuestos utiles como inhibidores de la raf quinasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632549A1 (de) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19826841A1 (de) * 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazine
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
DE19915365A1 (de) * 1999-04-06 2000-10-12 Merck Patent Gmbh Tetrahydropyridazin-Derivate

Also Published As

Publication number Publication date
NO20014845D0 (no) 2001-10-05
DE19915364A1 (de) 2000-10-12
CA2367051A1 (en) 2000-10-12
ID30381A (id) 2001-11-29
WO2000059484A2 (de) 2000-10-12
CN1355702A (zh) 2002-06-26
ZA200109120B (en) 2003-11-13
EP1143944A2 (de) 2001-10-17
MXPA01010034A (es) 2002-04-24
JP2002541095A (ja) 2002-12-03
RU2001129703A (ru) 2004-02-20
HUP0200311A3 (en) 2002-12-28
AU3811600A (en) 2000-10-23
AR023261A1 (es) 2002-09-04
CZ20013598A3 (cs) 2002-01-16
BR0009549A (pt) 2002-03-26
EP1143944A3 (de) 2002-09-11
NO20014845L (no) 2001-10-05
PL350963A1 (en) 2003-02-24
KR20020000550A (ko) 2002-01-05
WO2000059484A3 (de) 2001-08-23

Similar Documents

Publication Publication Date Title
AP2000001860A0 (en) Hypolipidemic benzothiazepine compounds.
LU91206I2 (fr) Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel)
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
HUP0105081A2 (hu) Triazolo[4,5-d]pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0402225A2 (hu) Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0401982A2 (hu) Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
FI930753A (fi) Nya fosfolipidderivat av nukleosider, deras framstaellning och deras anvaendning saosom antivirala laekemedel
ES8202334A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
HUP0204587A2 (en) 6-position substituted indoline, production and use thereof as a medicament
HU9601218D0 (en) Distamycin a analogue utilizable as antitumoral and antiviral medicines
HUP0203288A2 (hu) Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
AP1522A (en) Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them.
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
HUP0104033A2 (hu) Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk
IL81299A0 (en) Dihydrobenzofuran-and chromancarboxamide derivatives,their preparation and pharmaceutical compositions containing them
HUP0003718A2 (hu) Kondenzált tiofénszármazékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0200311A2 (hu) Aroil- vagy aralkanoil-piridazin-származékok alkalmazása gyógyszerkészítmények előállítására
EP0313458A3 (en) Imidazo(2,1-b)benzothiazoles and their acid addition salts, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them
HUP0101733A2 (hu) Szulfonil dipeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU643987B2 (en) Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
AU4995690A (en) New 1-arylsulphonyl-2-piperidin-one derivatives, process and intermediates for the preparation thereof, their application as medicinal products and compositions containing them
DK96086A (da) 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelse som laegemidler